Antiviral drug resistance and the need for development of new HIV-1 reverse transcriptase inhibitors.
about
Computational drug design strategies applied to the modelling of human immunodeficiency virus-1 reverse transcriptase inhibitorsCurrent perspectives on HIV-1 antiretroviral drug resistancePicomolar Inhibitors of HIV Reverse Transcriptase Featuring Bicyclic Replacement of a Cyanovinylphenyl GroupRecent Insights into the HIV/AIDS Pandemic.Recent findings on the mechanisms involved in tenofovir resistance.Monocytes-derived macrophages mediated stable expression of human brain-derived neurotrophic factor, a novel therapeutic strategy for neuroAIDS.Structure-based evaluation of non-nucleoside inhibitors with improved potency and solubility that target HIV reverse transcriptase variants.The HEPT Analogue WPR-6 Is Active against a Broad Spectrum of Nonnucleoside Reverse Transcriptase Drug-Resistant HIV-1 Strains of Different Serotypes.Potent Inhibitors Active against HIV Reverse Transcriptase with K101P, a Mutation Conferring Rilpivirine Resistance.Combination therapies, effectiveness, and adherence in patients with HIV infection: clinical utility of a single tablet of emtricitabine, rilpivirine, and tenofovir.In vitro and in vivo activities of AIC292, a novel HIV-1 nonnucleoside reverse transcriptase inhibitor.HIV Diagnosis and Treatment through Advanced Technologies."Old Dogs with New Tricks": exploiting alternative mechanisms of action and new drug design strategies for clinically validated HIV targets.Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2011-2014).Proteins, peptides, polysaccharides, and nucleotides with inhibitory activity on human immunodeficiency virus and its enzymes.Universal antiretroviral therapy for HIV-infected children: a review of the benefits and risks to consider during implementation.Differential effects of the G118R, H51Y, and E138K resistance substitutions in different subtypes of HIV integrase.Design, Synthesis, and Biological Evaluation of Novel 4-Aminopiperidinyl-linked 3,5-Disubstituted-1,2,6-thiadiazine-1,1-dione Derivatives as HIV-1 NNRTIs.Identification of highly conserved residues involved in inhibition of HIV-1 RNase H function by Diketo acid derivatives.2-Aminothiazolones as anti-HIV agents that act as gp120-CD4 inhibitors.Profile of disposition, tissue distribution and excretion of the novel anti-human immunodeficiency virus (HIV) agent W-1 in rats.Substituted indoles as HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent evaluation (WO2015044928).Synthesis and Preliminary Antiviral Activities of Piperidine-substituted Purines against HIV and Influenza A/H1N1 Infections.Emerging reverse transcriptase inhibitors for HIV-1 infection.Arylazolyl(azinyl)thioacetanilides: Part 19: Discovery of Novel Substituted Imidazo[4,5-b]pyridin-2-ylthioacetanilides as Potent HIV NNRTIs Via a Structure-based Bioisosterism ApproachSynthesis, crystal structure, anti-HIV, and antiproliferative activity of new pyrazolylthiazole derivatives
P2860
Q26777448-6906EC3C-22DF-4BDA-B8CF-B3F80FEF22A9Q26852626-85F7CEE7-A632-438B-833A-1DAA93AC9BB5Q27680431-56A150CA-172B-47F2-B642-B4E56636F183Q30235024-01E910E5-78F5-4652-9D96-4EC3ACB474C3Q33831709-F969C7E4-A7A6-400A-ABE1-0C6EE2056676Q35088011-4B5EC4C0-8D18-43D9-9E24-0BB2E7410C91Q35228851-FDC5677D-7FD5-436F-A0CF-123059BAA7B4Q35859896-17767B82-BD40-4DC2-B567-5C0DF309E366Q36146704-E53B2F49-4844-441F-BB26-B63112407CF9Q36603434-629CD3C4-34F6-4722-8943-189EAAB98FBEQ37263490-BFCB2E3B-F3BC-422C-BDD0-C7BE4AB3F7C7Q37683120-B8634ADF-17EA-436F-A7A5-AA4672A233C2Q38212854-00C6DF58-BA6B-4679-879F-ABCC6A48E4DAQ38260066-F08F08C9-2589-4720-B99A-E3FC7F1AC8CEQ38593985-B8D67591-9E1D-446C-A6D5-338AB854FFA6Q38660444-F10F86F4-3659-45F9-9422-89F15A6B5B42Q38924027-8AE9789E-F5EB-4E10-9CCC-0C70B792EF8EQ38943621-AB006ACA-BCEF-433B-9F0C-A1C9B5F3882EQ38968700-7FC9B86F-5C2C-4097-A747-1D660242B9CEQ39016799-74883FF4-FA97-4D3F-A581-11722AB31419Q40708931-A3EE5606-4CF6-4850-83EA-084E9438508FQ40841438-C627718F-8F89-40E2-9F2D-9B9F6DF351DBQ41534943-4F559FC5-0479-4C1B-94D3-F1274B8A3CDEQ53686168-323E75C4-654C-4553-BDFC-F8AE1ED770A8Q56786207-029583BD-38CC-416F-80BB-66406E9256DBQ57269131-B5C8D9B9-85E3-4B01-874D-B288F913C330
P2860
Antiviral drug resistance and the need for development of new HIV-1 reverse transcriptase inhibitors.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Antiviral drug resistance and ...... erse transcriptase inhibitors.
@ast
Antiviral drug resistance and ...... erse transcriptase inhibitors.
@en
type
label
Antiviral drug resistance and ...... erse transcriptase inhibitors.
@ast
Antiviral drug resistance and ...... erse transcriptase inhibitors.
@en
prefLabel
Antiviral drug resistance and ...... erse transcriptase inhibitors.
@ast
Antiviral drug resistance and ...... erse transcriptase inhibitors.
@en
P2093
P2860
P356
P1476
Antiviral drug resistance and ...... erse transcriptase inhibitors.
@en
P2093
Cécile L Tremblay
Eugene L Asahchop
Mark A Wainberg
Richard D Sloan
P2860
P304
P356
10.1128/AAC.00591-12
P407
P577
2012-06-25T00:00:00Z